Royal Bank of Canada’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,285
| Closed | -$10K | – | 6364 |
|
|
2024
Q2 | $10K | Buy |
3,285
+576
| +21% | +$1.75K | ﹤0.01% | 5930 |
|
|
2024
Q1 | $8K | Sell |
2,709
-890
| -25% | -$2.63K | ﹤0.01% | 5823 |
|
|
2023
Q4 | $10K | Buy |
3,599
+3,448
| +2,283% | +$9.58K | ﹤0.01% | 5943 |
|
|
2023
Q3 | $0 | Sell |
151
-121
| -44% | – | ﹤0.01% | 6559 |
|
|
2023
Q2 | $0 | Buy |
272
+249
| +1,083% | – | ﹤0.01% | 6766 |
|
|
2023
Q1 | $0 | Sell |
23
-3
| -12% | – | ﹤0.01% | 6645 |
|
|
2022
Q4 | $0 | Buy |
26
+2
| +8% | – | ﹤0.01% | 6727 |
|
|
2022
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 6928 |
|
|
2022
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 6880 |
|
|
2022
Q1 | $1K | Sell |
24
-1
| -4% | -$42 | ﹤0.01% | 7076 |
|
|
2021
Q4 | $1K | Sell |
25
-4
| -14% | -$160 | ﹤0.01% | 6938 |
|
|
2021
Q3 | $1K | Sell |
29
-259
| -90% | -$8.93K | ﹤0.01% | 6920 |
|
|
2021
Q2 | $29K | Buy |
288
+188
| +188% | +$18.9K | ﹤0.01% | 5859 |
|
|
2021
Q1 | $15K | Buy |
100
+91
| +1,011% | +$13.7K | ﹤0.01% | 6089 |
|
|
2020
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 6361 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6098 |
|
|
2020
Q2 | – | Sell |
-2
| Closed | -$1K | – | 6120 |
|
|
2020
Q1 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 5891 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | – | – | 6188 |
|
|
2019
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5977 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5702 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 5765 |
|